Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: An analysis of microbiological data

References

• Falagas ME, Apostolou KE, Pappas VD. Attributable mortality of candidaemia: a systematic review of matched cohort and case control studies. Eur J Clin Microbiol Infect Dis 2006; 25: 419–25
   PubMed Web of Science ®Google Scholar
• Bedini A, Venturelli C, Mussini C, Guaraldi G, Godeluppi M, Borghi V, et al. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary- care hospital. Clin Microbiol Infect 2006; 12: 75–80
   PubMed Web of Science ®Google Scholar
• Pasqualotto AC, Nedel WL, Machado TS, Severo LC. A 9-y study comparing risk factors and the outcome of paediatric patients and adults with nosocomial candidaemia. Mycopathologia 2005; 160: 111–6
   PubMedGoogle Scholar
• Tortorano AM, Peman J, Bernhardt H, , and 8 other authors. Epidemiology of candidaemia in Europe: results of a 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004;23:317–22.
   PubMed Web of Science ®Google Scholar
• Verma AK, Prasad KN, Singh M, Dixit AK, Ayyagari A. Candidaemia in patients of a tertiary health care hospital from north India. Indian J Med Res 2003; 117: 122–8
   PubMed Web of Science ®Google Scholar
• Vigouroux S, Morin O, Moreau P, Harousseau JL, Miplied N. Candidaemia in patients with haematological malignancies: analysis of 7 y experience in a single centre. Haematologica 2006; 91: 717–8
   PubMed Web of Science ®Google Scholar
• Chryssanthou E. Trends in antifungal susceptibility among Swedish Candida species bloodstream isolates from 1994 to 1998: comparison of the E-test and the Sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A reference method. J Clin Microbiol 2001; 39: 4181–3
   PubMed Web of Science ®Google Scholar
• Cuenca-Estrella M, Rodriguez D, Almirante B and 11 other authors. Barcelona Candidaemia Project Study Group: in vitro susceptibilities of bloodstream isolates of Candida species to 6 antifungal agents. Results from a population-based active surveillance programme, Barcelona, Spain, 2002–2003. J Antimicrob Chemother 2005;55:194–9.
   PubMed Web of Science ®Google Scholar
• Diekema DJ, Messer SA, Brueggemann AB, Coffman SL, Doern GV, Herwaldt LA, Pfaller MA. Epidemiology of candidaemia: 3-y results from the Emerging Infections and the Epidemiology of Iowa Organisms Study. J Clin Microbiol 2002; 40: 1298–1302
   PubMed Web of Science ®Google Scholar
• Ostrosky-Zeichner L, Rex JH, Pappas PG and 9 other authors. Antifungal susceptibility survey of 2000 bloodstream Candida isolates in the United States. Antimicrob Agents Chemother 2003;47:3149–54.
   PubMed Web of Science ®Google Scholar
• Takakura S, Fujihara N, Saito T, Kudo T, Iinuma Y, Ichiyama S. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to 6 antifungal agents including voriconazole and micafungin. J Antimicrob Chemother 2004; 53: 283–9
   PubMed Web of Science ®Google Scholar
• Rex JH, Pfaller MA, Walsh TJ, , and 8 other authors. Antifungal susceptibility testing: practical aspects and current challenges. Clin Microbiol Rev 2001;14:643–58.
   PubMed Web of Science ®Google Scholar
• Viudes A, Peman J, Canton E, Ubeda P, Lopez-Ribot JL, Gobernado M. Candidaemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur J Clin Microbiol Infect Dis 2002; 21: 767–74
   PubMed Web of Science ®Google Scholar
• Antunes AG, Pasqualotto AC, Diaz MC, d'Azevedo PA, Severo LC. Candidaemia in a Brazilian tertiary care hospital: species distribution and antifungal susceptibility patterns. Rev Inst Med Trop Sao Paulo 2004; 46: 239–41
   PubMedGoogle Scholar
• Capoor MR, Nair D, Deb M, Verma PK, Srivastava L, Aggarwal P. Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital. Jpn J Infect Dis 2005; 58: 344–8
   PubMed Web of Science ®Google Scholar
• Ellis M, Hedstrom U, Jumaa P, Bener A. Epidemiology, presentation, management and outcome of candidaemia in a tertiary care teaching hospital in the United Arab Emirates, 1995–2001. Med Mycol 2003; 41: 521–8
   PubMed Web of Science ®Google Scholar
• Foongladda S, Sakulmaiwatana P, Petlum P, Vanprapar N. Candida species, genotypes and antifungal susceptibility of Candida isolates from blood samples of patients at the largest tertiary care hospital in Thailand during 1999–2002. J Med Assoc Thai 2004; 87: 92–9
   PubMedGoogle Scholar
• Pasqualotto AC, Nedel WL, Machado TS, Severo LC. A comparative study of risk factors and outcome among outpatient-acquired and nosocomial candidaemia. J Hosp Infect 2005; 60: 129–34
   PubMedGoogle Scholar
• Bodey GP, Mardani M, Hanna HA, Boktour M, Abbas J, Girgawy E, et al. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Am J Med 2002; 112: 380–5
   PubMed Web of Science ®Google Scholar
• Guinea J, Sanchez-Somolinos M, Cuevas O, Pelaez T, Bouza E. Fluconazole resistance mechanisms in Candida krusei: the contribution of efflux-pumps. This study was partially presented at the 14th European Congress of Clinical Microbiology and Infectious Diseases, Prague, Czech Republic, May 2004 (Abstract P-1472). Med Mycol 2006; 44: 575–8
   PubMed Web of Science ®Google Scholar
• Vermitsky JP, Earhart KD, Smith WL, Homayouni R, Edlind TD, Rogers PD. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies. Mol Microbiol 2006; 61: 704–22
   PubMed Web of Science ®Google Scholar
• Weems JJ, Jr. Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin Infect Dis 1992; 14: 756–66
   PubMed Web of Science ®Google Scholar
• Vardakas KZ, Samonis G, Michalopoulos A, Soteriades ES, Falagas ME. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials. Crit Care Med 2006; 34: 1216–24
   PubMedGoogle Scholar